Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9089980rdf:typepubmed:Citationlld:pubmed
pubmed-article:9089980lifeskim:mentionsumls-concept:C0079459lld:lifeskim
pubmed-article:9089980lifeskim:mentionsumls-concept:C0882849lld:lifeskim
pubmed-article:9089980lifeskim:mentionsumls-concept:C0300926lld:lifeskim
pubmed-article:9089980lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:9089980pubmed:issue1lld:pubmed
pubmed-article:9089980pubmed:dateCreated1997-6-3lld:pubmed
pubmed-article:9089980pubmed:abstractTextWhen healthy people are given granulocyte colony stimulating factor (G-CSF) for 10 days the number of CD34+ cells in the peripheral blood begins to increase on the fourth day, reaches a maximum on the sixth day and then decreases. In this study, we further define the time and variability of peak mobilization of CD34+ cells. Twenty-two healthy people were given G-CSF (7.5 or 10 micrograms kg-1 day-1) subcutaneously each morning for 5 days and peripheral blood CD34+ cell counts were analysed immediately prior to the fourth (day 4) and fifth (day 5) G-CSF injection and 24 h after the fifth injection (Day 6). White blood cell (WBC) and neutrophil counts were greatest on day 6 [WBC = 43.8 +/- 13.9 x 10(9) L-1 (mean +/- 1 SD) and neutrophils = 36.6 +/- 12.8 x 10(9) L-1]. In contrast the CD34+ cell counts on day 6 (107 +/- 104 x 10(6) L-1) were less than on day 5 (128 +/- 136 x 10(6) L-1) (P = 0.048) but still greater than on day 4 (60.7 +/- 40.2 x 10(6) L-1) (P < 0.0001). The CD34+ cell counts of 10 donors were measured 2, 4 and 6 h after the fifth injection to determine if the counts increased further between days 5 and 6. The number of CD34+ cells in the blood on day 5 2 h after the fifth injection (193 +/- 277 x 10(6) L-1) was greater than the number prior to the injection (158 +/- 190 x 10(6) L-1), 4 h post-injection (139 +/- 158 x 10(6) L-1) and 6 h post-injection (170 +/- 236 x 10(6) L-1), but the differences were not significant (P = 0.29, 0.25 and 0.45). The number of CD34+ cells in the blood of 12 people were measured before and after the fourth G-CSF dose. Prior to the day 4 injection the CD34+ count was 61 +/- 40 x 10(6) L-1. At 2, 4 and 6 h the counts were 60 +/- 40, 61 +/- 29 and 64 +/- 30 x 10(6) L-1, respectively, and the differences were not significant (P = 0.99, P = 0.98, and P = 0.73). In conclusion, when healthy volunteers are given daily G-CSF injections, the number of mobilized CD34+ cells was the greatest on day 5, slightly less on day 6 and the least on day 4. If only one PBSC component is needed, PBSCs can be collected on day 5 after only 4 days of G-CSF. If PBSC components are collected on both days 5 and 6, the fifth dose can be given either before or after the collection of the first PBSC component.lld:pubmed
pubmed-article:9089980pubmed:languageenglld:pubmed
pubmed-article:9089980pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9089980pubmed:citationSubsetIMlld:pubmed
pubmed-article:9089980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9089980pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9089980pubmed:statusMEDLINElld:pubmed
pubmed-article:9089980pubmed:monthMarlld:pubmed
pubmed-article:9089980pubmed:issn0958-7578lld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:SmithJJlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:McCulloughJJlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:HerpAAlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:JaszczW BWBlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:CobbH WHWlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:StroncekD FDFlld:pubmed
pubmed-article:9089980pubmed:authorpubmed-author:IlstrupSSlld:pubmed
pubmed-article:9089980pubmed:issnTypePrintlld:pubmed
pubmed-article:9089980pubmed:volume7lld:pubmed
pubmed-article:9089980pubmed:ownerNLMlld:pubmed
pubmed-article:9089980pubmed:authorsCompleteYlld:pubmed
pubmed-article:9089980pubmed:pagination19-24lld:pubmed
pubmed-article:9089980pubmed:dateRevised2008-7-31lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:meshHeadingpubmed-meshheading:9089980-...lld:pubmed
pubmed-article:9089980pubmed:year1997lld:pubmed
pubmed-article:9089980pubmed:articleTitleThe kinetics of G-CSF mobilization of CD34+ cells in healthy people.lld:pubmed
pubmed-article:9089980pubmed:affiliationUniversity of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, USA.lld:pubmed
pubmed-article:9089980pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9089980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9089980lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9089980lld:pubmed